Horizon Pharma Inc (HZNP) 13.45 $HZNP Nasdaq st
Post# of 273315
Posted On: 04/08/2014 7:19:22 PM
Horizon Pharma Inc (HZNP) 13.45 $HZNP
Nasdaq stocks posting largest percentage decreases
AP - Thu Apr 03, 12:47PM CDT
NEW YORK (AP) — A look at the 10 biggest percentage decliners on Nasdaq at 1 p.m.:
Technical Data on Top Gainers -- Research on JinkoSolar, Horizon Pharma, YY Inc., and Questcor Pharma
PR Newswire - Wed Apr 02, 8:59AM CDT
On Tuesday, April 01, 2014, the US markets saw a positive sentiment, with the NASDAQ Composite closing at 4,268.04, up 1.64%, the Dow Jones Industrial Average ending the session at 16,532.61, up 0.46% and the S&P 500 edging 0.70% higher to finish the trading session at 1,885.52. The session saw a positive impact from Consumer Discretionary, Information Technology and Industrials sectors along with a drag from Utilities, and Consumer Staples sectors. A number of stocks saw large movements, including JinkoSolar Holding Co. Ltd (NYSE: JKS), Horizon Pharma Inc. (NASDAQ: HZNP), YY Inc. (NASDAQ: YY) and Questcor Pharmaceuticals Inc. (NASDAQ: QCOR). Free technical research on JKS, HZNP, YY and QCOR can be downloaded upon signing up at:
Biotechs Giving Uncle Sam the Shaft
Brian Orelli, The Motley Fool - Motley Fool - Mon Mar 31, 5:08PM CDT
As they say in real estate: location, location, location. Biotechs have been acquiring companies in large part for their address. Specifically, they're buying so they can move to places like Ireland, where taxes are substantially lower than in the...
Horizon Pharma grants inducement stock options to 26 new employees under NASDAQ Listing Rule 5635(c)(4)
M2 - Fri Mar 28, 4:55AM CDT
Pharmaceutical company Horizon Pharma (NasdaqGS:HZNP) said on Thursday that it has awarded inducement stock options to purchase an aggregate of 96,750 shares of its common stock to 26 new employees.
Horizon Pharma Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
Marketwire - Thu Mar 27, 9:20PM CDT
Horizon Pharma, Inc. (NASDAQ: HZNP) today announced that on March 27, 2014 the Compensation Committee of its Board of Directors approved the grant of inducement stock options to purchase an aggregate of 96,750 shares of common stock to 26 new employees.
Can Horizon Pharma (HZNP) Run Higher on Strong Earnings Estimate Revisions? - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Thu Mar 27, 7:47AM CDT
Positive earnings estimate revisions suggest that analysts are becoming more optimistic on HZNP’s earnings for the coming quarter and year.
Acquisitions, Appointments, and New Product Developments - Analyst Notes on Boston Scientific, Horizon Pharma, Alkermes, Agilent, and BD
PR Newswire - Wed Mar 26, 7:00AM CDT
Today, Analysts Review released its analysts' notes regarding Boston Scientific Corporation (NYSE: BSX), Horizon Pharma Inc. (NASDAQ: HZNP), Alkermes Plc (NASDAQ: ALKS), Agilent Technologies Inc. (NYSE: A), and Becton, Dickinson and Co. (NYSE: BDX). Private wealth members receive these notes ahead of publication. To reserve complementary membership, limited openings are available at: http://www.AnalystsReview.com/register
Pharma & Biotech Stock Outlook - March 2014 - Zacks Analyst Interviews
Arpita Dutt - Zacks Investment Research - Wed Mar 26, 1:17AM CDT
Pharma & Biotech Stock Outlook - March 2014 - Zacks Analyst Interviews
Pharma & Biotech Stock Outlook - March 2014 - Industry Outlook
Arpita Dutt - Zacks Investment Research - Wed Mar 26, 1:17AM CDT
Pharma & Biotech Stock Outlook - March 2014 - Industry Outlook
Is A Short Squeeze Ahead for Horizon Pharma (HZNP)? - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Tue Mar 25, 8:18AM CDT
Is A Short Squeeze Ahead for Horizon Pharma (HZNP)?
Horizon Pharma to Present at the 21st Annual Future Leaders in the Biotech Industry Conference
Marketwire - Tue Mar 25, 6:31AM CDT
Horizon Pharma, Inc. (NASDAQ: HZNP) today announced that Timothy P. Walbert, its chairman, president and chief executive officer, will present at the 21st Annual Future Leaders in the Biotech Industry Conference on Friday, March 28, 2014 at 3:30 p.m. Eastern Time in New York, NY. Mr. Walbert will provide an overview of Horizon and its corporate activities.
Roundtable Top Picks for the Week of Mar. 24th - Video Blog
Zacks Equity Research - Zacks Investment Research - Mon Mar 24, 3:52PM CDT
Ideas for Auto Parts, Financials and Pharmaceuticals. Opportunities covered include Motorcar Parts of America, Inc. (MPAA), Financial Select Sector SPDR Fund (XLF) and Horizon Pharmaceutical (HZNP).
3 Stocks Rising on Unusual Volume
at The Street - Mon Mar 24, 7:50AM CDT
Often when above-average volume moves into an equity, it precedes a large spike in volatility.
Horizon Pharma to Host Corporate Update Meeting on March 27, 2014
Marketwire - Mon Mar 24, 6:30AM CDT
Horizon Pharma, Inc. (NASDAQ: HZNP) will host a Corporate Update Meeting on Thursday, March 27, 2014 at 7:30 a.m. Eastern Time in New York, NY.
When Avoiding U.S. Taxes Is a Smart Play
David Williamson and Michael Douglass, The Motley Fool - Motley Fool - Sun Mar 23, 5:20PM CDT
One of the big winners in the pharmaceuticals space this week was Horizon Pharma , up 17% in a single day on news that it was moving to Ireland to avoid higher U.S. tax rates. The company accomplished the move by buying Ireland's own Vidara...
3 Humongous Health-Care Stocks This Week
Keith Speights, The Motley Fool - Motley Fool - Sat Mar 22, 7:00AM CDT
Don't worry if you're already out of the hunt for the $1 billion that will be awarded to the person who picks every bracket correctly in the NCAA basketball playoffs. You still have a shot at making some money -- by investing in health care. This...
Horizon Pharma to Buy Vidara, Shares Rise - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Thu Mar 20, 3:09PM CDT
Horizon Pharma announced that it will acquire Vidara Therapeutics International Ltd.
Horizon Pharma Inc. Acquires Vidara Therapeutics in a Reverse Merger Deal Worth $660M in Cash and Stock
ACCESSWIRE - Wed Mar 19, 11:30PM CDT
Barrick Gold Corporation (NYSE: ABX) - For an in-depth report on Barrick Gold Corporation follow: www.BullTrends.com/stockquote/ABX
Why Prothena, Galena Biopharma, and Horizon Pharma Are Today's 3 Best Stocks
Sean Williams, The Motley Fool - Motley Fool - Wed Mar 19, 4:15PM CDT
Janet Yellen's first chaired Federal Open Market Committee meeting was certainly a memorable one, with the broad-based S&P 500 hiccuping and heading lower after the FOMC announced its latest policy decisions. According to Yellen, the...
Nasdaq stocks posting largest percentage decreases
AP - Thu Apr 03, 12:47PM CDT
NEW YORK (AP) — A look at the 10 biggest percentage decliners on Nasdaq at 1 p.m.:
Technical Data on Top Gainers -- Research on JinkoSolar, Horizon Pharma, YY Inc., and Questcor Pharma
PR Newswire - Wed Apr 02, 8:59AM CDT
On Tuesday, April 01, 2014, the US markets saw a positive sentiment, with the NASDAQ Composite closing at 4,268.04, up 1.64%, the Dow Jones Industrial Average ending the session at 16,532.61, up 0.46% and the S&P 500 edging 0.70% higher to finish the trading session at 1,885.52. The session saw a positive impact from Consumer Discretionary, Information Technology and Industrials sectors along with a drag from Utilities, and Consumer Staples sectors. A number of stocks saw large movements, including JinkoSolar Holding Co. Ltd (NYSE: JKS), Horizon Pharma Inc. (NASDAQ: HZNP), YY Inc. (NASDAQ: YY) and Questcor Pharmaceuticals Inc. (NASDAQ: QCOR). Free technical research on JKS, HZNP, YY and QCOR can be downloaded upon signing up at:
Biotechs Giving Uncle Sam the Shaft
Brian Orelli, The Motley Fool - Motley Fool - Mon Mar 31, 5:08PM CDT
As they say in real estate: location, location, location. Biotechs have been acquiring companies in large part for their address. Specifically, they're buying so they can move to places like Ireland, where taxes are substantially lower than in the...
Horizon Pharma grants inducement stock options to 26 new employees under NASDAQ Listing Rule 5635(c)(4)
M2 - Fri Mar 28, 4:55AM CDT
Pharmaceutical company Horizon Pharma (NasdaqGS:HZNP) said on Thursday that it has awarded inducement stock options to purchase an aggregate of 96,750 shares of its common stock to 26 new employees.
Horizon Pharma Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
Marketwire - Thu Mar 27, 9:20PM CDT
Horizon Pharma, Inc. (NASDAQ: HZNP) today announced that on March 27, 2014 the Compensation Committee of its Board of Directors approved the grant of inducement stock options to purchase an aggregate of 96,750 shares of common stock to 26 new employees.
Can Horizon Pharma (HZNP) Run Higher on Strong Earnings Estimate Revisions? - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Thu Mar 27, 7:47AM CDT
Positive earnings estimate revisions suggest that analysts are becoming more optimistic on HZNP’s earnings for the coming quarter and year.
Acquisitions, Appointments, and New Product Developments - Analyst Notes on Boston Scientific, Horizon Pharma, Alkermes, Agilent, and BD
PR Newswire - Wed Mar 26, 7:00AM CDT
Today, Analysts Review released its analysts' notes regarding Boston Scientific Corporation (NYSE: BSX), Horizon Pharma Inc. (NASDAQ: HZNP), Alkermes Plc (NASDAQ: ALKS), Agilent Technologies Inc. (NYSE: A), and Becton, Dickinson and Co. (NYSE: BDX). Private wealth members receive these notes ahead of publication. To reserve complementary membership, limited openings are available at: http://www.AnalystsReview.com/register
Pharma & Biotech Stock Outlook - March 2014 - Zacks Analyst Interviews
Arpita Dutt - Zacks Investment Research - Wed Mar 26, 1:17AM CDT
Pharma & Biotech Stock Outlook - March 2014 - Zacks Analyst Interviews
Pharma & Biotech Stock Outlook - March 2014 - Industry Outlook
Arpita Dutt - Zacks Investment Research - Wed Mar 26, 1:17AM CDT
Pharma & Biotech Stock Outlook - March 2014 - Industry Outlook
Is A Short Squeeze Ahead for Horizon Pharma (HZNP)? - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Tue Mar 25, 8:18AM CDT
Is A Short Squeeze Ahead for Horizon Pharma (HZNP)?
Horizon Pharma to Present at the 21st Annual Future Leaders in the Biotech Industry Conference
Marketwire - Tue Mar 25, 6:31AM CDT
Horizon Pharma, Inc. (NASDAQ: HZNP) today announced that Timothy P. Walbert, its chairman, president and chief executive officer, will present at the 21st Annual Future Leaders in the Biotech Industry Conference on Friday, March 28, 2014 at 3:30 p.m. Eastern Time in New York, NY. Mr. Walbert will provide an overview of Horizon and its corporate activities.
Roundtable Top Picks for the Week of Mar. 24th - Video Blog
Zacks Equity Research - Zacks Investment Research - Mon Mar 24, 3:52PM CDT
Ideas for Auto Parts, Financials and Pharmaceuticals. Opportunities covered include Motorcar Parts of America, Inc. (MPAA), Financial Select Sector SPDR Fund (XLF) and Horizon Pharmaceutical (HZNP).
3 Stocks Rising on Unusual Volume
at The Street - Mon Mar 24, 7:50AM CDT
Often when above-average volume moves into an equity, it precedes a large spike in volatility.
Horizon Pharma to Host Corporate Update Meeting on March 27, 2014
Marketwire - Mon Mar 24, 6:30AM CDT
Horizon Pharma, Inc. (NASDAQ: HZNP) will host a Corporate Update Meeting on Thursday, March 27, 2014 at 7:30 a.m. Eastern Time in New York, NY.
When Avoiding U.S. Taxes Is a Smart Play
David Williamson and Michael Douglass, The Motley Fool - Motley Fool - Sun Mar 23, 5:20PM CDT
One of the big winners in the pharmaceuticals space this week was Horizon Pharma , up 17% in a single day on news that it was moving to Ireland to avoid higher U.S. tax rates. The company accomplished the move by buying Ireland's own Vidara...
3 Humongous Health-Care Stocks This Week
Keith Speights, The Motley Fool - Motley Fool - Sat Mar 22, 7:00AM CDT
Don't worry if you're already out of the hunt for the $1 billion that will be awarded to the person who picks every bracket correctly in the NCAA basketball playoffs. You still have a shot at making some money -- by investing in health care. This...
Horizon Pharma to Buy Vidara, Shares Rise - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Thu Mar 20, 3:09PM CDT
Horizon Pharma announced that it will acquire Vidara Therapeutics International Ltd.
Horizon Pharma Inc. Acquires Vidara Therapeutics in a Reverse Merger Deal Worth $660M in Cash and Stock
ACCESSWIRE - Wed Mar 19, 11:30PM CDT
Barrick Gold Corporation (NYSE: ABX) - For an in-depth report on Barrick Gold Corporation follow: www.BullTrends.com/stockquote/ABX
Why Prothena, Galena Biopharma, and Horizon Pharma Are Today's 3 Best Stocks
Sean Williams, The Motley Fool - Motley Fool - Wed Mar 19, 4:15PM CDT
Janet Yellen's first chaired Federal Open Market Committee meeting was certainly a memorable one, with the broad-based S&P 500 hiccuping and heading lower after the FOMC announced its latest policy decisions. According to Yellen, the...
(0)
(0)